Keros Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $7.8M | 118k | 66.00 |
| 2023-12-31 | $6.7M | 169k | 39.76 |
| 2023-09-30 | $3.1M | 98k | 31.88 |
| 2023-03-31 | $14M | 326k | 42.70 |
| 2022-12-31 | $20M | 412k | 48.02 |
| 2022-09-30 | $18M | 476k | 37.62 |
| 2021-12-31 | $1.9M | 32k | 58.50 |
| 2021-03-31 | $2.6M | 43k | 61.55 |
| 2020-12-31 | $233k | 3.3k | 70.48 |
| 2020-09-30 | $13k | 335 | 38.81 |
| 2020-06-30 | $35k | 943 | 37.12 |